Remove Clinical Research Remove Pharmaceutical Companies Remove Pharmaceuticals Remove Research
article thumbnail

Insights into Therapeutic Areas in Clinical Research

Quanticate

Advancements in preclinical and clinical research are driving major changes across various therapeutic areas, steering the industry into a new phase of medical innovation. Our aim is to provide valuable insights for industry professionals, stakeholders, and all those invested in the future of medical science.

article thumbnail

How to Fast-Track Clinical Research Timelines

PPD

Acceleration in every step of clinical research is critical to pharmaceutical developers. Yet, today’s clinical research sponsors face significant challenges. These delays financially disrupt the potential of both current and future clinical research. With a median delay of 12.2

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Beyond blood tests: The evolution of digital biomarkers in clinical research

Drug Discovery World

With a staggering 450,000 clinical trials 3 registered globally to address these pressing health issues, and an average failure rate of 90% 4 , the call to accelerate and revolutionise clinical research is paramount. They mark a significant shift in clinical research, utilising technology to capture real-time patient data.

article thumbnail

Understanding the Impact of the New EU Artificial Intelligence Act on Clinical Research

Advarra

The EU AI Act’s implications extend into clinical research, where AI is increasingly utilized for tasks like medical image analysis, natural language process for endpoint analysis, and generating/analyzing data for synthetic control arms. Non-EU companies must comply with the AI Act if their AI systems are used in the EU market.

article thumbnail

Proteomics grant programme open to Singapore researchers

Drug Discovery World

Proteomics company SomaLogic is sponsoring the Genomax Research Grant Award for researchers in Singapore, the company’s first grant in the APAC region. The post Proteomics grant programme open to Singapore researchers appeared first on Drug Discovery World (DDW).

Research 130
article thumbnail

Q&A with Mark Garner: The golden age of cancer research  

Drug Discovery World

Global Cancer Segment Market Manager at Agilent Technologies, recently sat down with DDW Editor Reece Armstrong to tell us about the developments in the ‘golden age’ of cancer research. RA: What is the current state of the cancer research industry? RA: How is Agilent supporting cancer research? Mark Garner, PhD.,

Research 246
article thumbnail

$11.4m raised to power a ‘precision medicine revolution’  

Drug Discovery World

Sano Genetics, a software company working to accelerate precision medicine research, has raised $11.4 Access and referrals for patients to join trials often depend on the hospital or location where they’re receiving treatment – which is why recruiting for clinical trials is one of the biggest challenges in research.